Hessen
Universitätsklinikum Frankfurt - Medizinische Klinik 2
Theodor-Stern-Kai 7
D-60590 Frankfurt am Main
D-60590 Frankfurt am Main
Leitung: Prof. Dr. med. Hubert Serve und Prof. Dr. med. Thomas Oellerich
Studien
-
INTEGRATE ATMP
-
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
-
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL
-
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (CASSIOPEIA)
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Studien
-
INTEGRATE ATMP
-
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
-
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL
-
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (CASSIOPEIA)
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells